Inbunden, Engelska, 2027
1 562 kr
Kommande
This book discusses the integration of nanotechnology and CRISPR/Cas9 system for precise cancer therapy. The initial chapter provides an in-depth overview of the CRISPR/Cas9 system, detailing the molecular structure of CRISPR RNA (crRNA) and the Cas9 protein, and explaining their interaction and targeting mechanisms. The book then explores CRISPR/Cas9 in cancer therapy, highlighting its use in identifying tumor suppressor genes, oncogenes, and understanding cancer progression. It covers CRISPR/Cas9's role in developing tailored cancer treatments and modifying immune cells for enhanced immunotherapy. The book analyzes techniques to enhance the accuracy and efficiency of CRISPR/Cas9, including advanced delivery methods like lipid nanoparticles, cell-penetrating peptides, and viral vectors. It discusses nanoparticles, viral and non-viral systems, and considerations for tissue selectivity and safety. Innovations in delivery system design, such as DNA nanocarriers, are examined to address immune responses. Further, the chapter examines the challenges in delivering CRISPR/Cas9 components and strategies to overcome these obstacles. The book also presents advancements in lipid nanoparticle and polymeric nanoparticle-mediated delivery for CRISPR/Cas9, including stability, targeted delivery, and applications in personalized medicine.The text:Highlight role of CRISPR/Cas9 in identifying cancer-related genes and understanding cancer progressionReviews cutting-edge techniques to enhance the delivery of CRISPR/Cas9 components into target cells.Focuses on overcoming challenges related to immune reactions and ensuring safe CRISPR/Cas9 delivery.Investigates methods to improve the precision and effectiveness of genome editing with CRISPR/Cas9.Covers the role of nanoparticles in achieving targeted and efficient delivery of CRISPR/Cas9 for personalized treatments.Explores the potential of CRISPR/Cas9 in improving the efficacy and precision of immunotherapy.This book is useful to researchers and students of cancer biology, nanobiotechnology, and pharmaceutical sciences.